Kineta to Participate in BIO Investor Forum Digital Seattle, WA — (October 2, 2020) Kineta, Inc., a clinical stage biotechnology

Kineta Receives Regulatory Approval for Initiation of Phase 1 Clinical Trials of KCP506 First in-human clinical trials will evaluate the

Kineta Invited to Present at August 2020 Investor Conferences Seattle, WA — (July 30, 2020) Kineta, Inc., a clinical stage

Kineta Announces Formation of New Immuno-oncology Focused Scientific Advisory Board Seattle, WA — (April 21, 2020) Kineta, Inc., a clinical

Kineta to Present at the Upcoming 2020 Solebury Trout  Virtual Investor Conference Seattle, WA — (March 24, 2020) Kineta, Inc.,

Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference Seattle, WA — (February 26, 2020)

Kineta Invited to Participate at the BIO CEO & Investor Conference Seattle, WA — (February 5, 2020) Kineta, Inc., a

Kineta Invited to Participate at the 2nd Annual Evercore ISI HealthCONx Conference Seattle, WA — (November 26, 2019) Kineta, Inc.,

Kineta Invited to Participate at October 2019 Investor Conferences Seattle, WA — (October 7, 2019) Kineta, Inc., a clinical stage